Press "esc" to clear
Go to Advanced Search
Showing results 4150 of 233

Article ID: 673333

Sandia Honored for Fighting Ebola, Analyzing Emerging Biotechnologies

Sandia National Laboratories

Researchers at Sandia National Laboratories just received recognition from the Secretary of Energy for their work to mitigate the effects of the 2014 Ebola epidemic. Reducing the amount of time Liberians who suspected they had Ebola spent waiting in large, open waiting rooms called Ebola treatment units was critical to controlling the outbreak. Sandia modeled and analyzed the West Africa nation’s blood sample transport system from the treatment units to diagnostic labs and made recommendations to improve turnaround time.

Released:
20-Apr-2017 10:45 AM EDT

Article ID: 673014

The "Geneva Signature" Measures the Safety and Efficiency of a Vaccine Against Ebola Virus Disease

Université de Genève (University of Geneva)

The 2014–2015 Ebola epidemic affected several countries in West Africa, leading to the death of more than 11'000 people. Although this epidemic of Ebolavirus disease is over, there is no knowing if, when or where another may strike. It is therefore more important than ever to find a reliable vaccine against this deadly disease. Research on vaccines, which was ongoing during the epidemic in West Africa, is now yielding promising results.

Released:
18-Apr-2017 10:00 AM EDT
BenjaminRush.jpg

Article ID: 673060

Could Yellow Fever Rise Again?

Perelman School of Medicine at the University of Pennsylvania

Many people might not have heard of the Aedes aegypti mosquito until this past year, when the mosquito, and the disease it can carry – Zika – began to make headlines. But more than 220 years ago, this same breed of mosquito was spreading a different and deadly epidemic right here in Philadelphia and just like Zika, this epidemic is seeing a modern resurgence, with Brazil at its epicenter.

Released:
17-Apr-2017 10:05 AM EDT
GytisDudas.jpg

Article ID: 672849

A Big-Picture Look at the World’s Worst Ebola Epidemic

Fred Hutchinson Cancer Research Center

An international effort to analyze the entire database of Ebola virus genomes from the 2013-2016 West African epidemic reveals insights into factors that sped or slowed the rampage and calls for using real-time sequencing and data-sharing to contain future viral disease outbreaks.

Released:
12-Apr-2017 1:30 PM EDT
texas-biomedical-research-1051x700.jpg

Article ID: 672784

Texas Biomed Part of Research Efforts to Screen and Develop Ebola Virus Drug

Texas Biomedical Research Institute

Dr. Robert Davey, Scientist at Texas Biomedical Research Institute, is part of a team of researchers working to find new drugs that will stop Ebola virus from growing inside infected cells. Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $4.1 million federal grant for this project.

Released:
11-Apr-2017 2:05 PM EDT

Article ID: 672717

New Model Maps Likelihood of Ebola Spillovers

University of Georgia

Ecologists at the University of Georgia have developed a model that maps the likelihood of Ebola virus “spillovers”—when the virus jumps from its long-term host to humans or animals such as great apes—across Africa on a month-by-month basis.

Released:
10-Apr-2017 2:05 PM EDT

Article ID: 672472

Pre-Existing Immunity to Dengue and West Nile Viruses May Cause Increased Risk in Zika-Infected

Mount Sinai Health System

As the Zika virus continues to spread rapidly across the globe, it might pose a particular risk to people previously infected with two related viruses, dengue and West Nile, researchers at the Icahn School of Medicine at Mount Sinai have found. Their study, published in the journal Science, may help explain the severe manifestations of Zika virus infection observed in specific populations, including those in South America.

Released:
4-Apr-2017 5:05 PM EDT
basler_500x500-360x360.jpg

Article ID: 671054

Georgia State Researcher Gets $4.1 Million Federal Grant to Develop Drug to Combat Ebola Virus

Georgia State University

Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university’s Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a five-year, $4.1 million federal grant to develop a drug targeting Ebola virus.

Released:
13-Mar-2017 10:00 AM EDT
BiocontainmentPhoto.jpg

Article ID: 668825

Ebola Grant Expanded From $12 Million to $24 Million

University of Nebraska Medical Center (UNMC)

Supplemental funding will allow three partner institutions to perform additional site visits, conduct more education and training courses, as well as build a special pathogens research network.

Released:
3-Feb-2017 7:00 AM EST

Article ID: 666968

UF Plays Key Role in Trial for Successful Ebola Vaccine

University of Florida

An international group of researchers associated with the World Health Organization has published its final report on the Ebola vaccine trial in Guinea, finding that the vaccine is a safe and effective way to prevent Ebola infection.

Released:
23-Dec-2016 10:05 AM EST

Showing results 4150 of 233

Chat now!